Literature DB >> 4012935

Thomsen-Friedenreich antigen in bladder tumors as detected by specific antibody: a possible marker of recurrence.

H Ohoka, H Shinomiya, M Yokoyama, K Ochi, M Takeuchi, S Utsumi.   

Abstract

TUR specimens of non-invasive transitional-cell carcinomas were examined for their expression of Thomsen-Friedenreich (T) antigen by indirect immunofluorescence staining using rabbit IgG antibody which was raised with desialated glycophorin. Nine (45%) out of 20 tumors of low grade (Grade I and II), and 5 (56%) of 9 tumors of high grade (III) were diffusely stained with anti-T (T-positive), whereas T-antigen in normal tissue was cryptic and stained only after neuraminidase treatment (cryptic T-positive). Of the T-negative tumors, 9 (45%) of the low grade but only one of the high grade tumors, were stained positively for the cryptic T-antigen. The rest of the tumors were devoid of the cryptic T-antigen. Eighty percent of both Tumors expressing T-antigen and those lacking the cryptic T-antigen recurred within two years. Recurrence was not influenced by initial histological grade.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4012935     DOI: 10.1007/bf00261564

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  13 in total

1.  Blood group MN antigens and precursors in normal and malignant human breast glandular tissue.

Authors:  G F Springer; P R Desai; I Banatwala
Journal:  J Natl Cancer Inst       Date:  1975-02       Impact factor: 13.506

Review 2.  Human carcinoma-associated precursor antigens of the blood group MN system and the host's immune responses to them.

Authors:  G F Springer; P R Desai; M S Murthy; H Tegtmeyer; E F Scanlon
Journal:  Prog Allergy       Date:  1979

3.  Blood group MN specific substances and precursors in normal and malignant human breast tissues.

Authors:  G F Springer; P R Desai; I Banatwala
Journal:  Naturwissenschaften       Date:  1974-10

4.  Glycoproteins: isolation from cellmembranes with lithium diiodosalicylate.

Authors:  V T Marchesi; E P Andrews
Journal:  Science       Date:  1971-12-17       Impact factor: 47.728

5.  Human blood-group MN and precursor specificities: structural and biological aspects.

Authors:  G F Springer; P R Desai
Journal:  Carbohydr Res       Date:  1975-03       Impact factor: 2.104

6.  Extent of desialation of blood group MM, NN, and MN antigens required for reactivity with human anti-T antibody and Arachis hypogaea lectin.

Authors:  G F Springer; P R Desai
Journal:  J Biol Chem       Date:  1982-03-25       Impact factor: 5.157

7.  Blood group precursor T-antigen expression in human urinary bladder carcinoma.

Authors:  J S Coon; R S Weinstein; J L Summers
Journal:  Am J Clin Pathol       Date:  1982-06       Impact factor: 2.493

8.  Peanut lectin binding sites in transitional cell carcinoma of the urinary bladder.

Authors:  T P Lehman; H S Cooper; S G Mulholland
Journal:  Cancer       Date:  1984-01-15       Impact factor: 6.860

9.  Monoclonal antibodies specific for the M- and N-forms of human glycophorin A.

Authors:  W L Bigbee; M Vanderlaan; S S Fong; R H Jensen
Journal:  Mol Immunol       Date:  1983-12       Impact factor: 4.407

10.  Altered reactivity for A, B, H antigens in transitional cell carcinomas of the urinary bladder. A study of the mechanisms involved.

Authors:  C Limas; P Lange
Journal:  Cancer       Date:  1980-09-15       Impact factor: 6.860

View more
  2 in total

1.  Flow cytometric evaluation of Thomsen-Friedenreich antigen on transitional cell cancer using monoclonal antibody.

Authors:  H Oda; T Oda; H Ohoka; M Yokoyama; M Takeuchi
Journal:  Urol Res       Date:  1990

2.  Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and InVitro Efficacy Analysis.

Authors:  Swetha Tati; John C Fisk; Julia Abdullah; Loukia Karacosta; Taylor Chrisikos; Padraic Philbin; Susan Morey; Diala Ghazal; Fatma Zazala; Joseph Jessee; Sally Quataert; Stephen Koury; David Moreno; Jing Ying Eng; Vladislav V Glinsky; Olga V Glinskii; Muctarr Sesay; Anthony W Gebhard; Karamveer Birthare; James R Olson; Kate Rittenhouse-Olson
Journal:  Neoplasia       Date:  2017-08-19       Impact factor: 5.715

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.